Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 885538)

1.

Clozapine-induced agranulocytosis. A genetic and epidemiologic study.

de la Chapelle A, Kari C, Nurminen M, Hernberg S.

Hum Genet. 1977 Jun 30;37(2):183-94.

PMID:
885538
2.

Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic.

Amsler HA, Teerenhovi L, Barth E, Harjula K, Vuopio P.

Acta Psychiatr Scand. 1977 Oct;56(4):241-8.

PMID:
920225
3.

Clozapine-induced agranulocytosis: a situation report up to August 1976.

Anderman B, Griffith RW.

Eur J Clin Pharmacol. 1977 Mar 11;11(3):199-201.

PMID:
852497
4.

[Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].

Jungi WF, Fischer J, Senn HJ, Hartlapp J, Pöldinger W, Kunz H, Krupp P.

Schweiz Med Wochenschr. 1977 Dec 10;107(49):1861-4. German.

PMID:
929152
5.

Agranulocytosis during treatment with chlozapine.

Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva IP.

Eur J Clin Pharmacol. 1977 Mar 11;11(3):193-8.

PMID:
856603
6.

Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.

Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, Howard A.

J Clin Psychiatry. 1988 Jul;49(7):271-7.

PMID:
3391979
7.

Letter: Clozapine and agranulocytosis.

Griffith RW, Saameli K.

Lancet. 1975 Oct 4;2(7936):657. No abstract available.

PMID:
52022
8.

Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies.

Claas FH.

Psychopharmacology (Berl). 1989;99 Suppl:S113-7. Review.

PMID:
2682726
9.

Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.

Lahdelma L, Appelberg B.

J Clin Psychiatry. 2012 Jun;73(6):837-42. doi: 10.4088/JCP.11m07244. Epub 2012 Mar 6.

PMID:
22480452
10.
11.

Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J.

J Clin Psychiatry. 1998;59 Suppl 3:3-7. Review.

PMID:
9541331
12.

Agranulocytosis during clozapine therapy.

Gaszner P, Makkos Z, Kosza P.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):603-7.

PMID:
11999915
13.

[Hematologic effects of clozapine: a review of the international experience].

Lamarque V.

Encephale. 1996 Dec;22 Spec No 6:35-6. French.

PMID:
9102319
14.

Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J.

Hum Psychopharmacol. 2006 Aug;21(6):387-91.

PMID:
16933201
15.

Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.

Hägg S, Rosenius S, Spigset O.

Int Clin Psychopharmacol. 2003 May;18(3):173-4.

PMID:
12702898
16.

[Hematologic effects of clozapine: evaluation of the international experience].

Lamarque V.

Encephale. 1995 Jun;21 Spec No 3:59-60. French.

PMID:
7628344
17.

Clozapine-associated agranulocytosis: risk and aetiology.

Krupp P, Barnes P.

Br J Psychiatry Suppl. 1992 May;(17):38-40. Review.

PMID:
1418887
18.

Clozapine-induced agranulocytosis.

Anger B, Reichert S, Heimpel H.

Blut. 1987 Jan;54(1):63-4. No abstract available.

PMID:
3801680
19.

Filgrastim treatment of three patients with clozapine-induced agranulocytosis.

Lamberti JS, Bellnier TJ, Schwarzkopf SB, Schneider E.

J Clin Psychiatry. 1995 Jun;56(6):256-9.

PMID:
7539786
20.

Blood dyscrasias in clozapine-treated patients in Italy.

Lambertenghi Deliliers G.

Haematologica. 2000 Mar;85(3):233-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk